"Antigens, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
| Descriptor ID |
D000951
|
| MeSH Number(s) |
D23.050.285
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Neoplasm".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Neoplasm".
This graph shows the total number of publications written about "Antigens, Neoplasm" by people in this website by year, and whether "Antigens, Neoplasm" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 3 | 3 |
| 2000 | 2 | 1 | 3 |
| 2001 | 7 | 3 | 10 |
| 2002 | 5 | 4 | 9 |
| 2003 | 1 | 4 | 5 |
| 2004 | 2 | 2 | 4 |
| 2005 | 5 | 8 | 13 |
| 2006 | 2 | 1 | 3 |
| 2007 | 3 | 5 | 8 |
| 2008 | 3 | 1 | 4 |
| 2009 | 4 | 1 | 5 |
| 2010 | 5 | 8 | 13 |
| 2011 | 7 | 2 | 9 |
| 2012 | 4 | 2 | 6 |
| 2013 | 6 | 2 | 8 |
| 2014 | 4 | 4 | 8 |
| 2015 | 4 | 5 | 9 |
| 2016 | 4 | 2 | 6 |
| 2017 | 6 | 4 | 10 |
| 2018 | 5 | 1 | 6 |
| 2019 | 6 | 4 | 10 |
| 2020 | 5 | 8 | 13 |
| 2021 | 7 | 3 | 10 |
| 2022 | 0 | 7 | 7 |
| 2023 | 1 | 2 | 3 |
| 2024 | 6 | 2 | 8 |
| 2025 | 4 | 3 | 7 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, Neoplasm" by people in Profiles.
-
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptor. Nat Commun. 2026 Feb 04; 17(1):1349.
-
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial. Nat Med. 2026 Jan; 32(1):258-269.
-
PepQueryMHC: rapid and comprehensive tumor antigen prioritization from immunopeptidomics data. Genome Biol. 2025 Dec 23; 26(1):434.
-
Identification of immunogenic KIF5B-RET fusion neopeptides driving immune stimulation in tumor specific CD8+ T cells. Front Immunol. 2025; 16:1635810.
-
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade. Nature. 2025 Nov; 647(8089):488-497.
-
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. Hum Vaccin Immunother. 2025 Dec; 21(1):2556591.
-
Sub-ciliary localization of CEP290 and effects of its loss in mouse photoreceptors during development. J Cell Sci. 2025 Oct 15; 138(20).
-
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors. Front Immunol. 2025; 16:1618404.
-
MAGE-A4 induces non-small cell lung cancer and tumor-promoting plasma cell accumulation. Sci Adv. 2025 Feb 14; 11(7):eads4227.
-
Tumor-associated antigen prediction using a single-sample gene expression state inference algorithm. Cell Rep Methods. 2024 Nov 18; 4(11):100906.